Keyphrases
Endometrial Cancer
100%
Hormone Replacement Therapy
100%
Combined Therapy
80%
Tibolone
60%
Estrogen
40%
Vaginal Micronized Progesterone
40%
Embase
20%
Cochrane Library
20%
Relative Risk Ratio
20%
Unopposed Estrogen
20%
Menopausal Women
20%
Systematic Literature Review
20%
Hazard Risk
20%
PubMed
20%
Placebo
20%
Hormone Therapy
20%
Hazard Ratio
20%
Odds Ratio
20%
Low Risk
20%
Progestin
20%
Uterus
20%
Risk-free
20%
Medicine and Dentistry
Uterine Cancer
100%
Systematic Review
100%
Hormone Substitution
100%
Combined Therapy
80%
Gestagen
60%
Tibolone
60%
Progesterone
40%
Menopause
20%
Odds Ratio
20%
Hazard Ratio
20%
Placebo
20%
Hormone Therapy
20%
Pharmacology, Toxicology and Pharmaceutical Science
Replacement Therapy
100%
Endometrium Cancer
100%
Progestin
60%
Tibolone
60%
Progesterone
40%
Endocrine Therapy
20%
Placebo
20%